Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Annu Int Conf IEEE Eng Med Biol Soc ; 2020: 6058-6061, 2020 07.
Article in English | MEDLINE | ID: mdl-33019352

ABSTRACT

Chronic pain affects both adolescent and adult Canadians. To study the effect of social rejection on pain management in adolescents with chronic pain, an algometer can be used in conjunction with functional Magnetic Resonance Imaging (fMRI) to measure brain activity in real time. The algometer uses an automated pneumatic control system that follows a customizable pain schedule, controlling the amount of airflow in and out of a pressure cuff wrapped around a human participant's thigh. Plastic components allow compatibility with an fMRI environment. Measurable pain stimuli allow repeatable pressure schedules to be administered with a standard deviation between trials of 300 Pa (2.25 mmHg). A Failure Mode Effects Analysis was used to reduce participant, researcher and facility harm, with multiple safety features incorporated into the design. Through the analysis of medical standards and studies, the algometer is shown to be biologically safe to use on research subjects within the suggested usage parameters of a maximum pressure of 42.6 kPa (320 mmHg) and a pressure application period of up to one hour. This makes it feasible for research studies using fMRI machines.


Subject(s)
Chronic Pain , Magnetic Resonance Imaging , Adolescent , Adult , Canada , Humans , Pain Measurement , Thigh
2.
Rev Sci Tech ; 16(1): 172-6, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9329115

ABSTRACT

The international trade in bee products is a complex issue as a result of the diverse uses of these products. This is especially true with regard to honey. In most cases, honey is imported for human consumption: the high purchase and shipping costs preclude the use of honey as feed for bees. For these reasons, the risk of transmitting disease through honey is minimal. However, this risk should not be ignored, especially in those countries where American foulbrood is not known to occur. The importation of pollen for bee feed poses a definite risk, especially since there are no acceptable procedures for determining whether pollen is free from pathogens, insects and mites. Routine drying of pollen would reduce the survival of mites and insects, but would not have any impact on bacterial spores. Phytosanitary certificates should be required for the importation of honey and pollen when destined for bee feed. The declaration on the phytosanitary certificate should include country of origin, and should state whether the following bee diseases and parasitic mites are present: American foulbrood disease, European foulbrood disease, chalkbrood disease, Varroa jacobsoni and Tropilaelaps clareae.


Subject(s)
Bees/microbiology , Bees/parasitology , Honey/microbiology , Honey/parasitology , Animals , Ascomycota/physiology , Bacillus/isolation & purification , Bacillus/physiology , Fatty Acids/adverse effects , Food Microbiology , Food Parasitology , Humans , Mites/physiology , Pollen/microbiology , Pollen/parasitology , Risk Factors , Spores, Bacterial , Transportation , Waxes/adverse effects
3.
Am J Vet Res ; 53(5): 706-10, 1992 May.
Article in English | MEDLINE | ID: mdl-1524295

ABSTRACT

Six healthy mature horses were orally administered a single dose of phenobarbital (26 mg/kg of body weight), then multiple doses (13 mg/kg) orally for 42 consecutive days. Seventeen venous blood samples were collected from each horse after the single dose study and again after the last dose on day 42. Plasma phenobarbital concentration was determined by use of a fluorescence assay validated for horses. Additional blood samples (n = 11) were collected on days 8 and 25 to determine peak and trough concentrations, as well as total body clearance. Phenobarbital disposition followed a one-compartment model. Mean kinetic variables after single and repeated orally administered doses (42 days) were: elimination half-life = 24.2 +/- 4.7 and 11.2 +/- 2.3 hours, volume of distribution = 0.960 +/- 0.060 and 0.914 +/- 0.119 L/kg, and clearance = 28.2 +/- 5.1 and 57.3 +/- 9.6 ml/h/kg, respectively. Results indicated that significant (P less than 0.05) difference in half-life and oral clearance existed between single and repeated dosing. The significant decrease in half-life after repeated dosing with phenobarbital may be indicative of enzyme induction. Significant difference was not observed between baseline serum enzyme concentration and concentration measured on day 42, except for gamma-glutamyltransferase activity, which was significantly increased on day 42 in 3 of the 6 horses. On the basis of increases in oral clearance observed over 42 days, dose adjustments may be required.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Horses/metabolism , Phenobarbital/pharmacokinetics , Absorption , Administration, Oral , Animals , Half-Life , Liver/drug effects , Phenobarbital/administration & dosage , Phenobarbital/adverse effects , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...